The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom

被引：0
|
作者：
Hollowell, J [1 ]
Ruigómez, A
Johansson, S
Wallander, MA
García-Rodríguez, LA
机构：
[1] AstraZeneca, Dept Epidemiol, R&D, S-43183 Molndal, Sweden
[2] Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain
来源：
BRITISH JOURNAL OF GENERAL PRACTICE | 2003年 / 53卷 / 489期
关键词：
warfarin; bleeding; incidence; United Kingdom;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The aim of this study was to estimate and explore the incidence of walfarin-related bleeding in a representative sample of patients in the United Kingdom. We identified 3958 Patients aged 40 to 84 years, newly treated with warfarin and with no phor history of bleeding from the General Practice Research Database, and followed them for 12 months. The overall incidence of first-time, idiopathic bleeding was 15.2 per 100 patient-years of current warfarin exposure. the incidence of fatal/hospitalised and referred bleeding was 3.5 and 2.6 per 100 patient-years, respectively.
引用
收藏
页码：312 / 314
页数：3
相关论文
共 50 条
  • [1] Glaucoma treatment adherence at a United Kingdom general practice
    A P Tse
    M Shah
    N Jamal
    A Shaikh
    [J]. Eye, 2016, 30 : 1118 - 1122
  • [2] Glaucoma treatment adherence at a United Kingdom general practice
    Tse, A. P.
    Shah, M.
    Jamal, N.
    Shaikh, A.
    [J]. EYE, 2016, 30 (08) : 1118 - 1122
  • [3] Incidence and treatment of heavy menstrual bleeding in general practice
    van den Brink, Marian J.
    Saaltink, Anne Linde
    Groenhof, Feikje
    Kollen, Boudewijn J.
    Berger, Marjolein Y.
    Lisman-van Leeuwen, Yvonne
    Dekker, Janny H.
    [J]. FAMILY PRACTICE, 2017, 34 (06) : 673 - 678
  • [4] Incidence of bleeding complications in patients on celecoxib and warfarin.
    Chung, L
    Wang, C
    Kearns, P
    Chakravarty, EF
    Bush, TM
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4087 - 4088
  • [5] Incidence of bleeding and thrombotic events in non-institutionalized paediatric patients using warfarin in the United Kingdom
    Maagdenberg, Hedy
    Souverein, Patrick C.
    Bierings, Marc B.
    de Boer, Anthonius
    Maitland-van der Zee, Anke H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 273 - 274
  • [6] Bleeding associated with doxycycline and warfarin treatment
    Baciewicz, AM
    Bal, BS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (09) : 1231 - 1231
  • [7] Thrombomodulin as a Marker for Bleeding Complications During Warfarin Treatment
    Lind, Marcus
    Boman, Kurt
    Johansson, Lars
    Nilsson, Torbjorn K.
    Ohlin, Ann-Kristin
    Birgander, Lisbeth Slunga
    Jansson, Jan-Hakan
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (13) : 1210 - 1215
  • [8] Incidence and predictors of severe bleeding during warfarin treatment
    Lindh, Jonatan D.
    Holm, Lennart
    Dahl, Marja-Liisa
    Alfredsson, Lars
    Rane, Anders
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 25 (02) : 151 - 159
  • [9] Incidence and predictors of severe bleeding during warfarin treatment
    Jonatan D. Lindh
    Lennart Holm
    Marja-Liisa Dahl
    Lars Alfredsson
    Anders Rane
    [J]. Journal of Thrombosis and Thrombolysis, 2008, 25 : 151 - 159
  • [10] Specialty Training for General Practice in the United Kingdom
    Ahluwalia, Sanjiv
    Swanwick, Tim
    [J]. JOURNAL OF AMBULATORY CARE MANAGEMENT, 2008, 31 (03): : 276 - 281
12345